ES8103170A1 - Un procedimiento para obtener una sustancia antibiotica - Google Patents

Un procedimiento para obtener una sustancia antibiotica

Info

Publication number
ES8103170A1
ES8103170A1 ES490236A ES490236A ES8103170A1 ES 8103170 A1 ES8103170 A1 ES 8103170A1 ES 490236 A ES490236 A ES 490236A ES 490236 A ES490236 A ES 490236A ES 8103170 A1 ES8103170 A1 ES 8103170A1
Authority
ES
Spain
Prior art keywords
antibiotic
acid addition
addition salts
present
designated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490236A
Other languages
English (en)
Other versions
ES490236A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of ES8103170A1 publication Critical patent/ES8103170A1/es
Publication of ES490236A0 publication Critical patent/ES490236A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G49/00—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00
    • C10G49/02—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used
    • C10G49/08—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used containing crystalline alumino-silicates, e.g. molecular sieves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J29/00—Catalysts comprising molecular sieves
    • B01J29/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/20—Silicates
    • C01B33/26—Aluminium-containing silicates, i.e. silico-aluminates
    • C01B33/28—Base exchange silicates, e.g. zeolites
    • C01B33/2807—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures
    • C01B33/2884—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures the aluminium or the silicon in the network being partly replaced
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C07C1/044—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof containing iron
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G35/00—Reforming naphtha
    • C10G35/04—Catalytic reforming
    • C10G35/06—Catalytic reforming characterised by the catalyst used
    • C10G35/065—Catalytic reforming characterised by the catalyst used containing crystalline zeolitic molecular sieves, other than aluminosilicates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2529/00—Catalysts comprising molecular sieves
    • C07C2529/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites, pillared clays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/827—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Geology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROCEDIMIENTO PARA OBTENER UNA SUSTANCIA ANTIBIOTICA QUE CONSTA DE LA BASE LIBRE A/16686 Y SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE ACEPTABLE. LA SUSTANCIA ANTIBIOTICA SE OBTIENE POR RECUPERACION MEDIANTE EXTRACCION SEPARADA DE CALDO Y MICELIO CON UN DISOLVENTE ORGANICO. EL ANTIBIOTICO ASI OBTENIDO SE TRATA CON UNA MEZCLA DE CLOROFORMO, ETANOL Y AGUA; EL PRODUCTO SE PURIFICA POR CROMATOGRAFIA EN COLUMNA DE GEL DE SILICE ELUYENDO CON UNA MEZCLA DE ACETONITRILO: HCL, CON LO QUE SE RECUPERA EL CLORHIDRATO DEL ANTIBIOTICO A/16686. ESTE ANTIBIOTICO SE CARACTERIZA EN SU FORMA DE CLORHIDRATO POR SER UN MATERIAL BLANCO, CRISTALINO, QUE FUNDE A 224-226GC; SER MUY SOLUBLE EN AGUA, DIMETILFORMAMIDA, METANOL, ETANOL, PROPANOL, BUTANO; INSOLUBLE EN ETER ETILICO, ETER DE PETROLEO Y BENCENO. ESTA SUSTANCIA TIENE UNA COMPOSICION DE 51,73 POR 100 DE CARBONO, 6,34 POR 100 DE H2, 9,96 POR 100 DE N2, 5,84 POR 100 DE CLORO (CONTENIDO TOTAL), 4,74 POR 100 CL- Y 1 POR 100 DE RESIDUO. ESTE COMPUESTO TIENE APLICACION COMO AGENTE ANTIBACTERIANO. C
ES490236A 1979-04-07 1980-04-02 Un procedimiento para obtener una sustancia antibiotica Granted ES490236A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7912298 1979-04-07

Publications (2)

Publication Number Publication Date
ES8103170A1 true ES8103170A1 (es) 1981-02-16
ES490236A0 ES490236A0 (es) 1981-02-16

Family

ID=10504421

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490236A Granted ES490236A0 (es) 1979-04-07 1980-04-02 Un procedimiento para obtener una sustancia antibiotica

Country Status (30)

Country Link
US (2) US4303646A (es)
JP (2) JPS5697237A (es)
AR (1) AR222217A1 (es)
AT (1) AT370130B (es)
AU (2) AU533951B2 (es)
BE (1) BE882632A (es)
CA (1) CA1142866A (es)
CH (1) CH655515B (es)
DE (1) DE3013246A1 (es)
DK (1) DK149336C (es)
ES (1) ES490236A0 (es)
FI (1) FI65630C (es)
FR (1) FR2452931A1 (es)
GR (1) GR67279B (es)
HK (1) HK23584A (es)
HU (1) HU181534B (es)
IE (1) IE49327B1 (es)
IL (1) IL59704A (es)
IT (1) IT1212411B (es)
LU (1) LU82327A1 (es)
MX (1) MX5958E (es)
NL (1) NL192989C (es)
NO (1) NO155496C (es)
NZ (1) NZ193357A (es)
PH (1) PH17230A (es)
PT (1) PT71064A (es)
SE (1) SE441188B (es)
SG (1) SG22687G (es)
YU (1) YU41917B (es)
ZA (1) ZA801629B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0046201B1 (en) 1980-08-16 1984-04-11 Gruppo Lepetit S.P.A. Antibiotic a/16686 factor a2, the process for the preparation thereof, and the co-produced antibiotic a/16686 factors a1 and a3
US4375513A (en) * 1980-12-18 1983-03-01 Eli Lilly And Company Biologically pure culture of Actinoplanes missouriensis
US4613503A (en) * 1984-10-11 1986-09-23 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US4859599A (en) * 1984-10-11 1989-08-22 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
GB8624806D0 (en) * 1986-10-16 1986-11-19 Pfizer Ltd Glycopeptide antibiotic
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
AU2001245263A1 (en) * 2000-01-21 2001-07-31 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
US7257562B2 (en) * 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
ATE292684T1 (de) * 2000-10-13 2005-04-15 Ecopia Biosciences Inc Ramoplaninbiosynthesegenkluster
US20030211567A1 (en) * 2001-07-24 2003-11-13 Ecopia Biosciences, Inc. Compositions, methods and systems for discovery of lipopeptides
CA2476567A1 (en) 2002-03-08 2003-09-18 Vicuron Pharmaceuticals Inc. A process for the production of ramoplanin-like amide derivatives
WO2003089641A2 (en) * 2002-04-17 2003-10-30 Ecopia Biosciences Inc. Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
US7317001B2 (en) * 2002-06-06 2008-01-08 Oscient Pharmaceuticals Corporation Use of ramoplanin to treat diseases associated with the use of antibiotics
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
WO2004096143A2 (en) * 2003-04-25 2004-11-11 Oscient Pharmaceuticals Corporation Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
CA2945768A1 (en) 2014-04-16 2015-10-22 Nanotherapeutics, Inc. Methods of treatment of c. difficile spores with ramoplanin
US20180002741A1 (en) 2016-07-01 2018-01-04 The United States Of America As Represented By The Department Of Veterans Affairs Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4038383A (en) * 1975-01-17 1977-07-26 Pfizer Inc. Mixture of antibiotics produced by a species of actinoplanes
US4001397A (en) * 1975-08-11 1977-01-04 Pfizer Inc. Antibiotic compound 41,012
US4115552A (en) * 1976-04-19 1978-09-19 Eli Lilly And Company Factor A and B of antibiotic A-4696
US4169887A (en) * 1978-02-21 1979-10-02 Pfizer Inc. Antibiotics produced by species of actinoplanes
JPS54135703A (en) * 1978-04-11 1979-10-22 Dainippon Pharmaceut Co Ltd Antibiotic ab-102 and preparation thereof

Also Published As

Publication number Publication date
AR222217A1 (es) 1981-04-30
PH17230A (en) 1984-07-03
NL192989C (nl) 1998-07-03
FR2452931B1 (es) 1983-07-01
NO155496B (no) 1986-12-29
HU181534B (en) 1983-10-28
MX5958E (es) 1984-09-06
HK23584A (en) 1984-03-23
DE3013246A1 (de) 1980-10-16
CA1142866A (en) 1983-03-15
IL59704A (en) 1983-11-30
SE441188B (sv) 1985-09-16
SG22687G (en) 1989-07-07
JPS5697237A (en) 1981-08-05
ATA187480A (de) 1982-07-15
FI800881A (fi) 1980-10-08
YU41917B (en) 1988-02-29
IL59704A0 (en) 1980-06-30
FR2452931A1 (fr) 1980-10-31
NO155496C (no) 1987-04-08
NO800869L (no) 1980-10-08
DK149336C (da) 1986-10-13
DK140080A (da) 1980-10-08
IE800697L (en) 1980-10-07
AT370130B (de) 1983-03-10
YU93580A (en) 1983-06-30
FI65630C (fi) 1984-06-11
IE49327B1 (en) 1985-09-18
US4328316A (en) 1982-05-04
AU5903680A (en) 1980-12-11
DK149336B (da) 1986-05-05
CH655515B (es) 1986-04-30
LU82327A1 (fr) 1981-12-02
PT71064A (en) 1980-05-01
DE3013246C2 (es) 1987-11-19
NL192989B (nl) 1998-03-02
FI65630B (fi) 1984-02-29
JPS6251274B2 (es) 1987-10-29
JPS62282579A (ja) 1987-12-08
SE8002601L (sv) 1980-12-01
AU535727B2 (en) 1984-04-05
ZA801629B (en) 1981-03-25
US4303646A (en) 1981-12-01
ES490236A0 (es) 1981-02-16
BE882632A (fr) 1980-10-03
IT8021162A0 (it) 1980-04-03
IT1212411B (it) 1989-11-22
JPS6320514B2 (es) 1988-04-27
AU533951B2 (en) 1983-12-22
GR67279B (es) 1981-06-26
NL8001982A (nl) 1980-10-09
AU5703680A (en) 1980-10-09
NZ193357A (en) 1982-12-07

Similar Documents

Publication Publication Date Title
ES8103170A1 (es) Un procedimiento para obtener una sustancia antibiotica
JPS5645485A (en) Production of c-15003pnd
ES8106177A1 (es) Un procedimiento para la preparacion de nuevos antibioticos de milbecina.
CA1266247C (en) ANTIBIOTIC PREPARED BY LYSOBACTER SP. SC14.067
ES485074A1 (es) Un metodo de produccion de la mezcla antibiotica a-21978
ES2010729A6 (es) Un procedimiento para prerparar un des-acil- antibiotico a 40926.
MY100478A (en) Antitumor antibiotic compound
ES480405A1 (es) Un procedimiento para la obtencion de sustancias antibioti- cas o sus derivados.
ES8105034A1 (es) Procedimiento para la produccion de una istamicina
ES480904A1 (es) Un procedimiento para la produccion del antibiotico mycopla-necin.
ES443463A1 (es) Un procedimiento para la produccion del complejo antibioticobu-2183.
ES439691A1 (es) Procedimiento para la produccion de una actividad antibioti-ca a base de cepas del genero actinoplanes.
ES8104400A1 (es) Un procedimiento para la produccion de un nuevo antibiotico designado com substancia bn-183 b.
ES8107303A1 (es) Un metodo para producir antibioticos c-14482 b1, b2 o b3
AU527251B2 (en) Antibiotic
ES471709A1 (es) Un procedimiento microbiologico para la preparacion de un nuevo complejo antibiotico
AU581621B2 (en) Antibiotic SB 22484
PT78325A (en) Process for preparing novel macrolides ptl-448
JPS5350395A (en) Preparation of antibiotics colstine
ES479116A1 (es) Procedimiento para la obtencion de una mezcla de antibioti- cos bm782 alfaii, bm782 alfa 2 y bm782 alfa ia.
GB1394231A (en) Process for the production of pepstatins having anti-pepsin activity
EP0195872A3 (en) Novel cell-cidal antibiotic 82-85-8a and its production

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20010217